Executive Summary

Decision-making requires a vast amount of structured information. Although paramount to establishing a representative description of a particular field, identifying and structuring information is a tedious task. When generating an information structure, it is essential to make it as complete as possible in order to analyze and draw correct conclusions from the field. For your convenience, BioSeeker Group has identified and structured more than 220 industry related lymphoma R&D projects, compiled in the first edition of this database. This collection of data describes the R&D activities in this field as near completely as possible. 

Compiling the information in a database file for convenient transfer of data to your preferred information system will save hundreds of working hours for you. Depending on the aim of your analysis, it will enable you to produce simple as well as advanced information analysis on the spot. Use the database to produce key tables and automated graphs in no more than a few minutes! 

This is one of the world's most comprehensive and updated information sources describing the structure of the lymphoma R&D situation. It includes information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapies, antigen- or cellular-based vaccines, liposomal and antiangiogenesis drugs. 

The information is structured in 9 different segments: 

> Company

> Drug name

> Developmental stage

> Therapy given

> Effect

> Effect 2

> Mechanism

> Mechanism 2

> General comments  

Release date: Dec 16, 2003 

Publisher: BioSeeker 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/BioSeeker.html#a449